Pre-treatment characteristics and long-term outcomes of recurrent-metastatic head and neck cancer patients treated with immune checkpoint inhibitors

被引:1
|
作者
Issa, M. [1 ]
Schultz, T. [1 ]
Xu, M. [1 ]
Bhateja, P. [1 ]
Karivedu, V. [1 ]
Dibs, K. [2 ]
Old, M. [3 ]
Kang, S. [3 ]
Gamez, M. [2 ]
Grecula, J. [2 ]
Jhawar, S. [2 ]
Mitchell, D. [2 ]
Seim, N. [3 ]
Agrawal, A. [3 ]
Ozer, E. [3 ]
Baliga, S. S. B. E. [2 ]
Carrau, R. [3 ]
Rocco, J. [3 ]
Blakaj, D. [2 ]
Bonomi, M. [1 ]
机构
[1] Ohio State Univ, Comprehens Canc Ctr James, Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Comprehens Canc Ctr James, OSUCCC, Radiat Oncol Dept, Columbus, OH 43210 USA
[3] Ohio State Univ, James Canc Hosp, Otolaryngol, Columbus, OH 43210 USA
关键词
D O I
10.1016/j.annonc.2020.08.1063
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
948P
引用
收藏
页码:S674 / S675
页数:2
相关论文
共 50 条
  • [21] Nutritional needs in patients with recurrent/metastatic Head & Neck Cancer (R/M HNSCC) receiving immune checkpoint inhibitors (ICI)
    Brown, Teresa
    Camilleri, Belinda
    Bauer, Judy
    Nottage, Michelle
    Hughes, Brett G. M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 125 - 126
  • [22] Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors
    Arribas, Lorena
    Plana, Maria
    Taberna, Miren
    Sospedra, Maria
    Vilarino, Noelia
    Oliva, Marc
    Pallares, Natalia
    Gonzalez Tampan, Ana Regina
    Miguel Del Rio, Luis
    Mesia, Ricard
    Baracos, Vickie
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] A nomogram based prognostic score to predict overall survival (OS) in recurrent-metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Mousa, L.
    Issa, M.
    Klamer, B.
    Pan, J.
    Old, M.
    Kang, S.
    Agrawal, A.
    Ozer, E.
    Carrau, R.
    Bhateja, P.
    Rupert, R.
    Jhawar, S.
    Mitchell, D.
    Gamez, M.
    Rocco, J.
    Blakaj, D.
    Bonomi, M. R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [24] Long term outcomes of patients with advanced/unresectable melanoma treated with immune checkpoint inhibitors
    Sonke, Eric
    Angeles, Arkhjamil
    Nguyen, Thao Phuong
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma
    Francesca Aroldi
    Mark R. Middleton
    American Journal of Clinical Dermatology, 2022, 23 : 331 - 338
  • [26] Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma
    Aroldi, Francesca
    Middleton, Mark R.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (03) : 331 - 338
  • [27] The emergence of long-term survivors in recurrent and metastatic squamous cell head and neck cancer
    Castet, Florian
    Brenes, Jesus
    Taberna, Miren
    Mesia, Ricard
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 160 - 168
  • [28] Long-term survival outcomes with immune checkpoint inhibitors (ICI) in metastatic uveal melanoma (MUM).
    Lee, Cha Len
    Walsh, Naomi
    Keane, Fergus
    Lynch, Emer
    Reddan, Tadhg
    Craig, Helen
    O'Meara, Aileen
    Smith, Deirdre
    O'Neill, Valerie
    Horgan, Noel
    Kennedy, Susan
    Gullo, Giuseppe
    Crown, John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] REHABILITATION OUTCOMES OF LONG-TERM SURVIVORS TREATED FOR HEAD AND NECK-CANCER
    DEBOER, MF
    PRUYN, JFA
    VANDENBORNE, B
    KNEGT, PP
    RYCKMAN, RM
    VERWOERD, CDA
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1995, 17 (06): : 503 - 515
  • [30] Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141
    Gillison, Maura L.
    Blumenschein, George
    Fayette, Jerome
    Guigay, Joel
    Colevas, A. Dimitrios
    Licitra, Lisa
    Harrington, Kevin J.
    Kasper, Stefan
    Vokes, Everett E.
    Even, Caroline
    Worden, Francis
    Saba, Nabil F.
    Docampo, Lara Carmen Iglesias
    Haddad, Robert
    Rordorf, Tamara
    Kiyota, Naomi
    Tahara, Makoto
    Jayaprakash, Vijayvel
    Wei, Li
    Ferris, Robert L.
    ONCOLOGIST, 2022, 27 (02): : E194 - E198